vs
Side-by-side financial comparison of ASTRONICS CORP (ATRO) and COLLEGIUM PHARMACEUTICAL, INC (COLL). Click either name above to swap in a different company.
ASTRONICS CORP is the larger business by last-quarter revenue ($240.1M vs $205.4M, roughly 1.2× COLLEGIUM PHARMACEUTICAL, INC). On growth, ASTRONICS CORP posted the faster year-over-year revenue change (15.1% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $15.8M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 13.9%).
Astronics Corporation is an American aerospace electronics corporation founded in 1968, headquartered in East Aurora, New York. It is traded on NASDAQ as Nasdaq: ATRO. It is known for lighting and electronics integrations on military, commercial, and business aircraft and semiconductor test systems.
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
ATRO vs COLL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $240.1M | $205.4M |
| Net Profit | — | $17.0M |
| Gross Margin | 33.3% | 62.5% |
| Operating Margin | 14.8% | 29.6% |
| Net Margin | — | 8.3% |
| Revenue YoY | 15.1% | 12.9% |
| Net Profit YoY | — | 35.3% |
| EPS (diluted) | $0.82 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $240.1M | $205.4M | ||
| Q3 25 | $211.4M | $209.4M | ||
| Q2 25 | $204.7M | $188.0M | ||
| Q1 25 | $205.9M | $177.8M | ||
| Q4 24 | $208.5M | $181.9M | ||
| Q3 24 | $203.7M | $159.3M | ||
| Q2 24 | $198.1M | $145.3M | ||
| Q1 24 | $185.1M | $144.9M |
| Q4 25 | — | $17.0M | ||
| Q3 25 | $-11.1M | $31.5M | ||
| Q2 25 | $1.3M | $12.0M | ||
| Q1 25 | $9.5M | $2.4M | ||
| Q4 24 | — | $12.5M | ||
| Q3 24 | $-11.7M | $9.3M | ||
| Q2 24 | $1.5M | $19.6M | ||
| Q1 24 | $-3.2M | $27.7M |
| Q4 25 | 33.3% | 62.5% | ||
| Q3 25 | 30.5% | 61.7% | ||
| Q2 25 | 25.8% | 57.7% | ||
| Q1 25 | 29.5% | 54.8% | ||
| Q4 24 | 29.8% | 54.0% | ||
| Q3 24 | 27.1% | 60.8% | ||
| Q2 24 | 28.0% | 62.5% | ||
| Q1 24 | 25.7% | 63.1% |
| Q4 25 | 14.8% | 29.6% | ||
| Q3 25 | 10.9% | 29.7% | ||
| Q2 25 | 2.3% | 18.7% | ||
| Q1 25 | 6.4% | 12.2% | ||
| Q4 24 | 4.3% | 20.9% | ||
| Q3 24 | 4.1% | 21.9% | ||
| Q2 24 | 3.8% | 32.7% | ||
| Q1 24 | 0.9% | 34.1% |
| Q4 25 | — | 8.3% | ||
| Q3 25 | -5.2% | 15.0% | ||
| Q2 25 | 0.6% | 6.4% | ||
| Q1 25 | 4.6% | 1.4% | ||
| Q4 24 | — | 6.9% | ||
| Q3 24 | -5.8% | 5.9% | ||
| Q2 24 | 0.8% | 13.5% | ||
| Q1 24 | -1.7% | 19.1% |
| Q4 25 | $0.82 | $0.48 | ||
| Q3 25 | $-0.31 | $0.84 | ||
| Q2 25 | $0.04 | $0.34 | ||
| Q1 25 | $0.26 | $0.07 | ||
| Q4 24 | $-0.07 | $0.36 | ||
| Q3 24 | $-0.34 | $0.27 | ||
| Q2 24 | $0.04 | $0.52 | ||
| Q1 24 | $-0.09 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.2M | $386.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $140.1M | $301.7M |
| Total Assets | $706.7M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $386.7M | ||
| Q3 25 | $13.5M | $285.9M | ||
| Q2 25 | $13.5M | $222.2M | ||
| Q1 25 | $24.8M | $197.8M | ||
| Q4 24 | $9.3M | $162.8M | ||
| Q3 24 | $5.2M | $120.0M | ||
| Q2 24 | $2.9M | $271.6M | ||
| Q1 24 | $5.3M | $318.0M |
| Q4 25 | $140.1M | $301.7M | ||
| Q3 25 | $108.9M | $274.8M | ||
| Q2 25 | $271.6M | $232.2M | ||
| Q1 25 | $266.8M | $234.4M | ||
| Q4 24 | $256.1M | $228.8M | ||
| Q3 24 | $249.2M | $234.3M | ||
| Q2 24 | $257.9M | $216.6M | ||
| Q1 24 | $251.7M | $222.2M |
| Q4 25 | $706.7M | $1.7B | ||
| Q3 25 | $682.2M | $1.6B | ||
| Q2 25 | $646.7M | $1.6B | ||
| Q1 25 | $662.2M | $1.6B | ||
| Q4 24 | $648.8M | $1.7B | ||
| Q3 24 | $651.6M | $1.6B | ||
| Q2 24 | $644.9M | $1.1B | ||
| Q1 24 | $630.0M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.6M | $123.0M |
| Free Cash FlowOCF − Capex | $15.8M | $122.4M |
| FCF MarginFCF / Revenue | 6.6% | 59.6% |
| Capex IntensityCapex / Revenue | 4.9% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 7.25× |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $327.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.6M | $123.0M | ||
| Q3 25 | $34.2M | $78.4M | ||
| Q2 25 | $-7.6M | $72.4M | ||
| Q1 25 | $20.6M | $55.4M | ||
| Q4 24 | $26.4M | $84.6M | ||
| Q3 24 | $8.4M | $-9.0M | ||
| Q2 24 | $-6.3M | $67.4M | ||
| Q1 24 | $2.0M | $61.9M |
| Q4 25 | $15.8M | $122.4M | ||
| Q3 25 | $21.0M | $78.3M | ||
| Q2 25 | $-12.2M | $72.4M | ||
| Q1 25 | $18.5M | $54.6M | ||
| Q4 24 | $23.2M | $84.1M | ||
| Q3 24 | $6.5M | $-9.2M | ||
| Q2 24 | $-8.1M | $67.1M | ||
| Q1 24 | $439.0K | $61.4M |
| Q4 25 | 6.6% | 59.6% | ||
| Q3 25 | 9.9% | 37.4% | ||
| Q2 25 | -6.0% | 38.5% | ||
| Q1 25 | 9.0% | 30.7% | ||
| Q4 24 | 11.1% | 46.2% | ||
| Q3 24 | 3.2% | -5.8% | ||
| Q2 24 | -4.1% | 46.2% | ||
| Q1 24 | 0.2% | 42.3% |
| Q4 25 | 4.9% | 0.3% | ||
| Q3 25 | 6.2% | 0.1% | ||
| Q2 25 | 2.2% | 0.0% | ||
| Q1 25 | 1.0% | 0.4% | ||
| Q4 24 | 1.5% | 0.3% | ||
| Q3 24 | 0.9% | 0.2% | ||
| Q2 24 | 0.9% | 0.2% | ||
| Q1 24 | 0.9% | 0.4% |
| Q4 25 | — | 7.25× | ||
| Q3 25 | — | 2.49× | ||
| Q2 25 | -5.81× | 6.05× | ||
| Q1 25 | 2.17× | 22.92× | ||
| Q4 24 | — | 6.75× | ||
| Q3 24 | — | -0.96× | ||
| Q2 24 | -4.08× | 3.44× | ||
| Q1 24 | — | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
COLL
Segment breakdown not available.
